Management of Hematuria in Children

O N Ray Bignall1, Bradley P Dixon2

  • 1Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center.

Insights

This review offers pediatric providers a guide to diagnosing and managing hematuria (blood in urine) in children. It emphasizes timely referral for definitive care, improving outcomes for kidney and urinary tract diseases.

Area of Science:

  • Pediatric Nephrology
  • Urology
  • Diagnostic Medicine

Background:

  • Hematuria, a common finding in pediatric urology and nephrology, necessitates accurate diagnosis and management.
  • Varied treatment strategies exist for hematuria, with recent guidelines offering evidence-based approaches for glomerular diseases.

Purpose of the Study:

  • To provide pediatric providers with a framework for evaluating microscopic and gross hematuria.
  • To update on the pathogenesis, clinical features, and treatment of kidney and urinary tract diseases presenting with hematuria.
  • To facilitate appropriate and timely subspecialty referral for definitive care.

Main Methods:

  • Review of diagnostic evaluation for microscopic and gross hematuria.
  • Synthesis of current knowledge on pathogenesis, clinical features, and treatment strategies.
  • Incorporation of recent guidelines, such as those from Kidney Diseases Improving Global Outcomes (KDIGO).

Main Results:

  • Highlights heterogeneity in treatment but emphasizes KDIGO guidelines for glomerular diseases.
  • Summarizes updates in treatment strategies based on advances in molecular pathogenesis and long-term outcomes for non-glomerular diseases.

Conclusions:

  • Updated knowledge on hematuria epidemiology and management improves pediatric care.
  • Appropriate management avoids unnecessary testing and ensures timely definitive treatment or referral.
  • This review aims to enhance the primary care provider's role in managing pediatric hematuria.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
307
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
438
Impression Management Techniques I: Managing Appearances01:29

Impression Management Techniques I: Managing Appearances

Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
220
Managing Impressions01:19

Managing Impressions

Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
173
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
657
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
545